NIKKEI 225
27,444.78 +59.53 (+0.22%) HANG SENG
19,851.79 -63.89 (-0.32%) CRUDE OIL
69.44 +0.18 (+0.26%) GOLD FUTURES
1,977.90 -5.90 (-0.30%) DOW
32,237.53 +132.33 (+0.41%) Bitcoin GBP
22,780.20 +189.13 (+0.84%)
AbbVie Inc. (ABBV)
After hours:
| Previous close | 155.30 |
| Open | 155.28 |
| Bid | 157.50 x 800 |
| Ask | 158.24 x 800 |
| Day's range | 154.59 - 158.48 |
| 52-week range | 134.09 - 175.91 |
| Volume | |
| Avg. volume | 6,384,056 |
| Market cap | 278.769B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 23.41 |
| EPS (TTM) | 6.75 |
| Earnings date | 27 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | 5.92 (3.81%) |
| Ex-dividend date | 13 Apr 2023 |
| 1y target est | 163.87 |
- Motley Fool
Better Buy: AbbVie vs. Johnson & Johnson
AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ) did something many other stocks didn't last year. After all, these stocks offer a track record of earnings growth and dividend increases. The company's mega-blockbuster immunology drug, Humira, recently started facing competition in the U.S. And AbbVie predicts that this will result in a 37% decline in the drug's sales this year.
- Zacks
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
- Motley Fool
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.
